(Q41049521)

26 September 2017

Antitumor effect of the nucleoside analogs 2-chlorodeoxyadenosine and 2',2'-difluorodeoxycytidine on human hepatoma HepG2 cells (English)

1 reference

26 September 2017

hepatocellular carcinoma

1 reference

I Graziadei

1

1 reference

26 September 2017

T Kelly

2

1 reference

26 September 2017

M Schirmer

3

1 reference

26 September 2017

F H Geisen

4

1 reference

26 September 2017

W Vogel

5

1 reference

26 September 2017

G Konwalinka

6

1 reference

26 September 2017

1 March 1998

1 reference

26 September 2017

Journal of Hepatology

1 reference

26 September 2017

28

1 reference

26 September 2017

3

1 reference

26 September 2017

504-509

1 reference

Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver

26 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980326-7

7 January 2021

Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980326-7

7 January 2021

Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980326-7

7 January 2021

Hepatitis C virus infection is associated with the development of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980326-7

7 January 2021

A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980326-7

7 January 2021

Therapy of unresectable hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980326-7

7 January 2021

Hepatocellular carcinoma in cirrhotics

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980326-7

7 January 2021

Treatment of small hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980326-7

7 January 2021

A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980326-7

7 January 2021

Comparison of resection, liver transplantation and transcatheter oily chemoembolization in the treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980326-7

7 January 2021

Treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980326-7

7 January 2021

Cancer statistics, 1995.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980326-7

7 January 2021

The influence of the schedule and the dose of gemcitabine on the anti-tumour efficacy in experimental human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980326-7

7 January 2021

Inhibitory effects of the nucleoside analogue gemcitabine on prostatic carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980326-7

7 January 2021

Gemcitabine: current status of phase I and II trials

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980326-7

7 January 2021

Gemcitabine in leukemia: a phase I clinical, plasma, and cellular pharmacology study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980326-7

7 January 2021

A phase I clinical, plasma, and cellular pharmacology study of gemcitabine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980326-7

7 January 2021

Deoxycytidine kinase from human leukemic spleen: preparation and characteristics of homogeneous enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980326-7

7 January 2021

Stereoselective binding of niguldipine enantiomers to alpha 1A-adrenoceptors labeled with [3H]5-methyl-urapidil

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980326-7

7 January 2021

Deoxycytidine kinase-mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980326-7

7 January 2021

10.1016/S0168-8278(98)80326-7

Identifiers

DOI

1 reference

26 September 2017

1 reference